Results 101 to 110 of about 578,438 (161)

The number of additional high molecular risk mutations predicts outcome after hematopoietic stem cell transplantation in primary and secondary myelofibrosis

Blood Cancer Journal
Maria Chiara Finazzi, Silvia Salmoiraghi, Francesca Valsecchi, Chiara Pavoni, Clara Belotti, Anna Grassi, Alessandra Algarotti, Federico Lussana, Benedetta Rambaldi, Giuliana Rizzuto, Gianluca Cavallaro, Annalisa Condorelli, Marta Bellini, Orietta Spinelli, Alessandro Rambaldi   +14 more
doaj   +1 more source

The triple A (AAA) model globally recapitulates adverse outcomes in essential thrombocythemia

Blood Cancer Journal
Luca Tosoni, Gian Luca Morelli, Gaia Tomadini, Davide Lazzarotto, Carla Filì, Erica Simeone, Maria Elena Zannier, Chiara Callegari, Matteo Fanin, Giulia Battaglia, Melissa Bergnach, Daniela Damiani, Renato Fanin, Mario Tiribelli   +13 more
doaj   +1 more source

Bone Marrow Transplantation

CA: A Cancer Journal for Clinicians, 1986
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Bone Marrow

Magnetic Resonance Imaging Clinics of North America, 2010
This article describes the composition of bone marrow and the normal progression of bone marrow changes as they occur throughout the aging process, and provides examples of pitfalls and variants that may simulate disease.
Darra T, Murphy, Michael R, Moynagh, Stephen J, Eustace, Eoin C, Kavanagh   +3 more
openaire   +2 more sources

Bone Marrow Purging for Autologous Bone Marrow Transplantation

Leukemia & Lymphoma, 1993
High dose therapy with the resulting myeloablation rescued by infusion of autologous bone marrow (ABMT) has become a major treatment option for an increasing number of patients with hematologic and solid tumors. ABMT has several potential advantages over allogeneic transplantation.
J G, Gribben, L M, Nadler
openaire   +2 more sources

Bone marrow transplantation

Current Opinion in Immunology, 1989
Bone marrow transplantation for treatment of certain hematologic and nonhematologic diseases is rapidly becoming the treatment of choice for a large number of patients. Over 10,000 marrow transplants have been performed, and over 200 marrow transplant units currently exist.
P C, Buchsel, J, Kelleher
openaire   +4 more sources

Bone marrow penicilliosis

British Journal of Haematology, 2002
link_to_subscribed_fulltext
So, CC, Wong, KF
openaire   +4 more sources

Bone marrow transplantation

Medical Journal of Australia, 1992
Over the last 20 years allogeneic bone marrow transplantation from an HLA-identical sibling donor has become the treatment of choice for a number of human haematological malignancies, severe aplastic anaemia, some congenital diseases of the immune and haemopoietic systems, and some inborn errors of metabolism.
D, Wujcik, S, Downs
openaire   +4 more sources

Bone and Bone Marrow; Interactions

2019
Disturbance of the system leads to bone diseases characterized by a loss of bone mass and alteration of bone quality.
Spruyt, Delphine, Gillet, Céline, Rasschaert, Joanne   +2 more
openaire   +2 more sources

The preservation of bone marrow

Cryobiology, 1964
I do not wish t,o get too involved with clinical questions concerning the need or usefulness of bone marrow therapy in medicine. The administration of bone marrow as a source of stem cells has been indicated in the treatment of the radiat’ion syndrome in man, although there are some clinicians who regard the use of foreign marrow as either useless or ...
openaire   +2 more sources